The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Product Launch

19 May 2009 07:00

Embargoed Release: 07:00hrs Tuesday 19 May 2009

SOPHEON PLC ("Sopheon" or the "Company") Sopheon Launches Idea Labâ„¢ Software Solution: Linking Idea Development to Strategic Product Planning and Execution Sopheon, the international provider of software and services for productlifecycle management, today announces the introduction of an addition to itsflagship software system, Accolade®, designed specifically for use ingenerating, nurturing and developing new product ideas. Called Idea Labâ„¢, thenew solution is the result of a partnership between Sopheon and Hype Software,a German-based supplier of idea management software. The new offering expandsAccolade's capacity to strengthen the front-end of the product innovationprocess, creating the first solution in the industry to provide all-in-onesupport for strategic product planning, idea development and innovation processexecution.In most companies, ideation efforts suffer from a lack of focus: too many ideasand not enough resources. Idea Lab can be used to launch and manage campaigns,publicise and motivate participation, and to establish communities ofinnovators who can solicit, share and evaluate ideas. Idea Lab supports scoringand filtering of ideas, as well as voting-based assessment. The softwarecontains process elements that allow submitted ideas to be challenged andexpanded. High-value ideas are forwarded into a gated process for conceptdevelopment. The rest can be stored in an idea bank for future consideration.Idea Lab allows users to arrange ideas by categories such as innovation type,product line, enabling technology or target market, making it easy to findthose that are relevant to specific business issues. Ideas can be ranked,merged or rejected, and similar ideas can be grouped inside portfolios. Staffare incentivised by built-in reward and recognition mechanisms. Idea Lab alsofeatures a navigation engine, Idea Browserâ„¢, that enables easy discovery withinthe solution's repository of concepts, campaigns and idea challenges, inspiringfurther ideation.One of the greatest shortcomings of traditional idea and innovation managementsoftware is that it focuses entirely on the generation, organisation and, inthe best cases, evaluation of ideas. There is no systematic alignment ofideation with strategic planning, and no support to help users traverse thepotential "dead zones" that separate the generation of ideas from getting thoseideas into the developmental pipeline and through to the market. Idea Lab,however, can be linked out of the box to Accolade's broader capabilitiesincluding product planning, product portfolio management, and innovationprocess automation and governance. This integration surmounts the challenges oftransitioning from one process stage to another. At the front end of theinnovation cycle, Accolade's Vision Strategistâ„¢ component delivers automatedsupport for the development of strategic product plans. The plans feed intoIdea Lab, where they contribute to the evaluation of the strategic fit andviability of submitted ideas. The most promising concepts seamlessly migratefrom Idea Lab into the user's Accolade-supported gate- or phase-basedinnovation processes, reducing the time it takes to turn ideas into products.Accolade also supplies the product portfolio management, commercialisation andpost-launch support required to manage newly created products until they areretired from the marketplace."Many organisations struggle to effectively integrate ideation with otherphases of the innovation process," said Andy Michuda, chief executive officerof Sopheon. "In the absence of such integration, potentially valuable ideas areeasily mired in repositories or fumbled in the hand-off to development. Withthe introduction of Idea Lab, we can help companies bridge the process gaps atthe front-end of the innovation cycle and establish direct connections betweenproduct planning, ideation and execution. We expect that Idea Lab will havestrong appeal both to current Accolade customers and to the broad population ofcompanies that are looking for ways to ensure that they get maximum businessbenefit from the ideas they generate."

Accolade® is a registered trademark of Sopheon plc. Idea Labâ„¢, Idea Browserâ„¢ and Vision Strategistâ„¢ are trademarks of Sopheon plc. All other trademarks are the sole property of their respective owners

For further information contact:

Barry Mence, Chairman Sopheon plc + 44 (0) 1483 685 735

Arif Karimjee, CFO Vikki Krause Hansard Communications + 44 (0) 207 245 1100 + 44 (0) 7515 922906 Claire Verhagen Citigate First Financial + 31 (0) 205 754 010 Paul Davies Seymour Pierce + 44 (0) 207 107 8000 About SopheonSopheon is an international provider of software and services thathelp organisations improve the business impact of product innovation. Sopheon'ssolutions automate and govern the innovation process, enabling companies toincrease revenue and profits from new products. Sopheon's solutions are used byindustry leaders throughout the world, including BASF, Cadbury Schweppes,Corning, Electrolux, General Motors, Honeywell, Motorola and SAB Miller.Sopheon is listed on the AIM Market of the London Stock Exchange and on theEuronext in the Netherlands. For more information, please visitwww.sopheon.com.

vendor
Date   Source Headline
21st Feb 20247:00 amRNSCancellation - Sopheon Plc
20th Feb 20244:31 pmRNSScheme of Arrangement becomes Effective
20th Feb 20247:30 amRNSSuspension - Sopheon plc
16th Feb 20241:40 pmRNSIssue of Equity, PDMR Dealing and Rule 2.9
16th Feb 20241:35 pmRNSCourt Sanction of Scheme of Arrangement
16th Feb 20249:04 amRNSForm 8.5 (EPT/NON-RI) - Sopheon PLC
14th Feb 20248:32 amRNSForm 8.5 (EPT/NON-RI)
13th Feb 20245:30 pmRNSSopheon
9th Feb 20243:30 pmRNSForm 8.3 - SPHN LN
9th Feb 20249:35 amRNSForm 8.3 - Sopheon plc
9th Feb 20249:14 amRNSForm 8.5 (EPT/NON-RI)
8th Feb 20242:00 pmRNSResults of Court Meeting and General Meeting
17th Jan 20241:31 pmRNSHolding(s) in Company
17th Jan 20249:42 amRNSForm 8.3 - Sopheon plc
16th Jan 20245:45 pmRNSPublication of Scheme Document
15th Jan 202410:53 amRNSForm 8.3 - Sopheon plc
15th Jan 20248:13 amRNSForm 8.3 - SOPHEON PLC
12th Jan 20243:22 pmRNSForm 8.3 - Sopheon PLC
11th Jan 20248:50 amRNSSatisfaction of NSIA Condition
11th Jan 20248:49 amRNSForm 8.3 - SOPHEON PLC
10th Jan 20249:13 amRNSForm 8.3 - SOPHEON PLC
9th Jan 202412:35 pmRNSForm 8.3 - Sopheon plc
9th Jan 20248:48 amRNSForm 8.3 - SOPHEON PLC
8th Jan 202412:22 pmRNSIssue of Equity
8th Jan 20248:31 amRNSForm 8.3 - SOPHEON PLC
4th Jan 20249:45 amRNSForm 8.3 - SOPHEON PLC
2nd Jan 20245:18 pmRNSForm 8.3 - Sopheon Plc
2nd Jan 20249:07 amRNSForm 8.3 - SOPHEON PLC
22nd Dec 20231:00 pmRNSRecommended Cash Offer
15th Dec 20238:39 amRNSForm 8.5 (EPT/NON-RI)
13th Dec 20238:32 amRNSForm 8.5 (EPT/NON-RI)
12th Dec 202310:55 amRNSForm 8.5 (EPT/NON-RI)
11th Dec 20238:37 amRNSForm 8.5 (EPT/NON-RI)
8th Dec 202310:41 amRNSForm 8.5 (EPT/NON-RI)
6th Dec 20238:36 amRNSForm 8.5 (EPT/NON-RI)
5th Dec 20239:16 amRNSForm 8.5 (EPT/NON-RI)
4th Dec 20236:18 pmRNSRule 2.9 Announcement
4th Dec 202312:30 pmRNSIssue of Equity
28th Nov 20237:00 amRNSOffer update - extension to PUSU Deadline
17th Nov 202311:39 amRNSForm 8.5 (EPT/NON-RI)
15th Nov 20239:30 amRNSForm 8.5 (EPT/NON-RI)
14th Nov 20232:59 pmRNSForm 8.3 - SOPHEON PLC
10th Nov 202311:40 amRNSForm 8.5 (EPT/NON-RI)
10th Nov 202311:09 amRNSForm 8.3 - Rivomore Limited - Sopheon plc - Amend
9th Nov 20239:15 amRNSForm 8.5 (EPT/NON-RI)
8th Nov 202312:57 pmRNSForm 8.3 - Sopheon plc
8th Nov 202310:25 amRNSForm 8.5 (EPT/NON-RI) - Sopheon PLC
8th Nov 20237:00 amRNSForm 8 (OPD) Sopheon plc
7th Nov 202311:24 amRNSForm 8.5 (EPT/NON-RI)
6th Nov 20231:03 pmRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.